JP2022533448A5 - - Google Patents
Info
- Publication number
- JP2022533448A5 JP2022533448A5 JP2021569494A JP2021569494A JP2022533448A5 JP 2022533448 A5 JP2022533448 A5 JP 2022533448A5 JP 2021569494 A JP2021569494 A JP 2021569494A JP 2021569494 A JP2021569494 A JP 2021569494A JP 2022533448 A5 JP2022533448 A5 JP 2022533448A5
- Authority
- JP
- Japan
- Prior art keywords
- polynucleotide
- vector
- expression cassette
- expression
- human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962851411P | 2019-05-22 | 2019-05-22 | |
| US62/851,411 | 2019-05-22 | ||
| PCT/US2020/034171 WO2020237130A1 (en) | 2019-05-22 | 2020-05-22 | Ube3a genes and expression cassettes and their use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022533448A JP2022533448A (ja) | 2022-07-22 |
| JP2022533448A5 true JP2022533448A5 (OSRAM) | 2023-10-31 |
| JP7616668B2 JP7616668B2 (ja) | 2025-01-17 |
Family
ID=73458642
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021569494A Active JP7616668B2 (ja) | 2019-05-22 | 2020-05-22 | Ｕｂｅ３ａ遺伝子および発現カセットならびにそれらの使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US12465655B2 (OSRAM) |
| EP (1) | EP3973059A4 (OSRAM) |
| JP (1) | JP7616668B2 (OSRAM) |
| KR (1) | KR20210158859A (OSRAM) |
| CN (1) | CN114127296B (OSRAM) |
| AU (1) | AU2020279387A1 (OSRAM) |
| CA (1) | CA3139678A1 (OSRAM) |
| EA (1) | EA202193214A1 (OSRAM) |
| IL (1) | IL287943A (OSRAM) |
| MX (1) | MX2021014248A (OSRAM) |
| SG (1) | SG11202112470YA (OSRAM) |
| WO (1) | WO2020237130A1 (OSRAM) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2023006445A (es) * | 2020-12-01 | 2023-08-10 | Univ Pennsylvania | Composiciones y usos de estas para el tratamiento del síndrome de angelman. |
| CN120265299A (zh) * | 2022-06-07 | 2025-07-04 | 吉乔公司 | 用于调节表达的剂 |
| TW202434734A (zh) * | 2023-02-08 | 2024-09-01 | 美商銀杏生物工作室有限公司 | 天使症候群的基因療法 |
| WO2025128816A1 (en) * | 2023-12-13 | 2025-06-19 | Kicho Inc. | Methods of modulating expression of ube3a gene |
| WO2025213123A1 (en) * | 2024-04-05 | 2025-10-09 | Encoded Therapeutics, Inc. | Methods and compositions for increasing expression of ube3a |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4501729A (en) | 1982-12-13 | 1985-02-26 | Research Corporation | Aerosolized amiloride treatment of retained pulmonary secretions |
| US5399346A (en) | 1989-06-14 | 1995-03-21 | The United States Of America As Represented By The Department Of Health And Human Services | Gene therapy |
| US5478745A (en) | 1992-12-04 | 1995-12-26 | University Of Pittsburgh | Recombinant viral vector system |
| US6093570A (en) | 1995-06-07 | 2000-07-25 | The University Of North Carolina At Chapel Hill | Helper virus-free AAV production |
| US6040183A (en) | 1995-06-07 | 2000-03-21 | University Of North Carloina At Chapel Hill | Helper virus-free AAV production |
| CA2265460A1 (en) | 1996-09-11 | 1998-03-19 | The Government Of The United States Of America, Represented By The Secre Tary, Department Of Health And Human Services | Aav4 vector and uses thereof |
| US6156303A (en) | 1997-06-11 | 2000-12-05 | University Of Washington | Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom |
| AU762220B2 (en) | 1998-05-28 | 2003-06-19 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | AAV5 vector and uses thereof |
| CA2347129A1 (en) | 1998-09-22 | 2000-03-30 | University Of Florida | Methods for large-scale production of recombinant aav vectors |
| EP1127150B1 (en) | 1998-11-05 | 2007-05-16 | The Trustees Of The University Of Pennsylvania | Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same |
| ATE454445T1 (de) | 1998-11-10 | 2010-01-15 | Univ North Carolina | Virusvektoren und verfahren für ihre herstellung und verabreichung. |
| CA2410901C (en) | 2000-06-01 | 2012-03-20 | University Of North Carolina At Chapel Hill | Methods and compounds for controlled release of recombinant parvovirus vectors |
| ATE318923T1 (de) | 2000-06-01 | 2006-03-15 | Univ North Carolina | Doppelsträngige parvovirus-vektoren |
| JP6294876B2 (ja) * | 2012-06-25 | 2018-03-14 | アイオーニス ファーマシューティカルズ， インコーポレーテッドＩｏｎｉｓ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． | Ｕｂｅ３ａ−ａｔｓ発現の調節 |
| PL2900686T3 (pl) | 2012-09-28 | 2021-01-25 | The University Of North Carolina At Chapel Hill | Wektory aav ukierunkowane na oligodendrocyty |
| CN105793425B (zh) * | 2013-06-17 | 2021-10-26 | 布罗德研究所有限公司 | 使用病毒组分靶向障碍和疾病的crispr-cas系统和组合物的递送、用途和治疗应用 |
| WO2015060722A1 (en) * | 2013-10-24 | 2015-04-30 | Uniqure Ip B.V. | Aav-5 pseudotyped vector for gene therapy for neurological diseases |
| EP4344741A3 (en) | 2014-11-21 | 2024-08-28 | The University of North Carolina at Chapel Hill | Aav vectors targeted to the central nervous system |
| EP4154914B1 (en) | 2015-05-07 | 2024-08-28 | University of South Florida | Modified ube3a gene for a gene therapy approach for angelman syndrome |
| US20180346531A1 (en) * | 2015-09-15 | 2018-12-06 | Regents Of The University Of California | Compositions and methods for delivering biotherapeutics |
| UA125963C2 (uk) * | 2015-11-12 | 2022-07-20 | Ф. Хоффманн-Ля Рош Аг | Олігонуклеотид для індукції батьківської експресії ube3a |
| RU2019143627A (ru) * | 2017-06-28 | 2021-07-28 | Юниверсити Оф Соус Флорида | Модифицированный ген ube3a для генной терапии синдрома ангельмана |
| JP2022525564A (ja) * | 2019-03-21 | 2022-05-17 | ピーティーシー セラピューティクス， インコーポレイテッド | アンジェルマン症候群を治療するためのベクターおよび方法 |
| US20220305098A1 (en) * | 2019-08-22 | 2022-09-29 | The Regents Of The University Of California | Ube3a for the treatment of angelman syndrome |
-
2020
- 2020-05-22 EA EA202193214A patent/EA202193214A1/ru unknown
- 2020-05-22 JP JP2021569494A patent/JP7616668B2/ja active Active
- 2020-05-22 SG SG11202112470YA patent/SG11202112470YA/en unknown
- 2020-05-22 AU AU2020279387A patent/AU2020279387A1/en active Pending
- 2020-05-22 KR KR1020217041626A patent/KR20210158859A/ko not_active Withdrawn
- 2020-05-22 CN CN202080050918.0A patent/CN114127296B/zh active Active
- 2020-05-22 CA CA3139678A patent/CA3139678A1/en active Pending
- 2020-05-22 EP EP20809370.8A patent/EP3973059A4/en active Pending
- 2020-05-22 MX MX2021014248A patent/MX2021014248A/es unknown
- 2020-05-22 WO PCT/US2020/034171 patent/WO2020237130A1/en not_active Ceased
- 2020-05-22 US US17/612,833 patent/US12465655B2/en active Active
-
2021
- 2021-11-09 IL IL287943A patent/IL287943A/en unknown
-
2025
- 2025-10-15 US US19/359,449 patent/US20260102519A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20220331409A1 (en) | Factor ix gene therapy | |
| US20240197918A1 (en) | Tissue-targeted modified aav capsids and methods of use thereof | |
| JP2022549380A5 (OSRAM) | ||
| JP2021087431A5 (OSRAM) | ||
| JP2024009857A5 (OSRAM) | ||
| JP2021513999A5 (OSRAM) | ||
| JP2021533805A5 (OSRAM) | ||
| JP2023514242A5 (OSRAM) | ||
| JP2022524434A5 (OSRAM) | ||
| JP2022551744A5 (OSRAM) | ||
| CN116732069A (zh) | 酸性α-葡萄糖苷酶变体及其用途 | |
| CA3158518A1 (en) | Triple function adeno-associated virus (aav)vectors for the treatment of c9orf72 associated diseases | |
| JP2023503850A5 (OSRAM) | ||
| KR20250115422A (ko) | 반복적 요소의 적절한 패키징을 위한 아데노 연관 바이러스 벡터 | |
| WO2022226375A1 (en) | Tissue-targeted modified aav capsids and methods of use thereof | |
| JP2023059858A5 (OSRAM) | ||
| JP2024530023A5 (OSRAM) | ||
| KR20240095165A (ko) | 근이영양증의 치료 | |
| Ortolano et al. | Present and future of adeno associated virus based gene therapy approaches | |
| JP2021534766A5 (OSRAM) | ||
| JP2023542131A5 (OSRAM) | ||
| JP2023515795A5 (OSRAM) | ||
| Chen | Adeno-associated virus vectors for human gene therapy | |
| JP2025508987A (ja) | Ｇｌｐ－１受容体アゴニスト融合物の送達のためのａａｖベクター | |
| JP2025515356A5 (OSRAM) |